| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA799639 | F | Compound was tested for its inhibitory concentration against rhinovirus 1B through plaque-inhibition assay at 50 ug/disk using monolayers of M-HeLa cells | rhinovirus type 1b | 10 | organism-based format | Scientific Literature | ||
| 2. | ALA799640 | F | Compound at 40 uM was tested for its percentage inhibitory concentration against rhinovirus 1B through plaque-inhibition assay at 50 ug/disk using monolayers of M-HeLa cells | rhinovirus type 1b | 5 | organism-based format | Scientific Literature | ||
| 3. | ALA799641 | F | Compound at 8 uM was tested for its percentage inhibitory concentration against rhinovirus 1B through plaque-inhibition assay at 50 ug/disk using monolayers of M-HeLa cells | rhinovirus type 1b | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA799642 | F | Compound was tested for its inhibitory concentration against rhinovirus 1B through plaque-inhibition assay at 50 ug/disk using monolayers of M-HeLa cells | rhinovirus type 1b | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA804275 | F | Compound was tested for its percentage inhibitory concentration through plaque-inhibition assay at 50 microg per disk using monolayers of M-HeLa cells. | rhinovirus type 1b | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA804248 | F | In vitro activity against Rhinovirus type 1B by plaque inhibition assay. | Enterovirus | 35 | organism-based format | Scientific Literature | ||
| 7. | ALA804249 | F | In vitro activity against rhinovirus type 1B was determined by plaque inhibition assay; - = Inactive at 50 ug/disk | Enterovirus | 11 | organism-based format | Scientific Literature | ||
| 8. | ALA804250 | F | In vitro activity against rhinovirus type 1B was determined by plaque inhibition assay; Inactive at 50 ug/disk, T=Toxic | Enterovirus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA804251 | F | Inhibitory activity against rhinovirus type 1B | rhinovirus type 1b | 30 | organism-based format | Scientific Literature | ||
| 10. | ALA804912 | F | Minimum inhibitory concentration against human rhinovirus serotype 1B | human rhinovirus serotype 1b | 2 | organism-based format | Scientific Literature | ||
| 11. | ALA849860 | F | Expanded antirhinoviral activity against the rhinovirus serotype 1B | human rhinovirus type 1b | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA849861 | F | Tested for antirhinoviral activity against the rhinovirus serotype 1B | human rhinovirus type 1b | 10 | organism-based format | Scientific Literature | ||
| 13. | ALA858519 | F | Tested for antirhinoviral activity against the rhinovirus serotype 1B; IA is inactive | human rhinovirus type 1b | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA1931089 | F | Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as inhibition of virus induced-plaque formation after 3 days by neutral red-based plaque reduction assay | Human rhinovirus 1B | 17 | organism-based format | Scientific Literature | ||
| 15. | ALA1931096 | F | Antiviral activity against Human rhinovirus 1B assessed as reduction in infectivity titers at 42 uM after 1 hr using HeLa cell monolayers by plaque assay (Rvb = 5.33 * 10'6 PFU/mL) | Human rhinovirus 1B | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA1931097 | F | Antiviral activity against Human rhinovirus 1B in human HeLa cell monolayers assessed as reduction of viral infectivity at 42 uM at pH 5 pre-treated for 1 hr before mild acid treatment measured after 30 mins by plaque assay (Rvb = 3.8 log PFU/mL) | Human rhinovirus 1B | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA1931098 | F | Antiviral activity against Human rhinovirus 1B in human HeLa cell monolayers assessed as reduction of viral infectivity at 42 uM at 56 degC pre-treated for 1 hr before thermal treatment measured after 20 mins by plaque assay (Rvb = 2.9 log PFU/mL) | Human rhinovirus 1B | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA1931099 | F | Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yield at 42 uM treated together with viral inoculum after 10 hrs by neutral red-based plaque reduction assay | Human rhinovirus 1B | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA1931100 | F | Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yield at 42 uM at 4 degC treated immediately after viral adsorption after 1 hr by neutral red-based plaque reduction assay | Human rhinovirus 1B | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA1931101 | F | Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yield at 42 uM treated 15 mins after viral adsorption measured after 10 hrs by neutral red-based plaque reduction assay | Human rhinovirus 1B | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!